SCHEMBL5752156

SCHEMBL5752156

CCOC(=O)C(Cc1ccc2c(c1)C(C)(C)CO2)C(=O)c1cccc(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RARB P10826 3/20 0.36
RARG P13631 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
RARA P10276 2/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
CHRNA1 P02708 2/20 0.34
CHRNG P07510 2/20 0.34
CHRNB1 P11230 2/20 0.34
CHRNB2 P17787 2/20 0.34
SLC6A2 P23975 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2428821 0.76 MDM2 (0.51) KMT2APPARGPPARAMAPTLMNA
SCHEMBL5752567 0.75 SLC6A2 (0.43) KMT2AMEN1SMN1; SMN2L3MBTL1PPARG
SCHEMBL5748618 0.75 SLC6A2 (0.43) KMT2AMEN1SMN1; SMN2L3MBTL1PPARG
SCHEMBL5751964 0.74 ACHE (0.43) KMT2ATSHRSMN1; SMN2L3MBTL1PPARG
SCHEMBL5751669 0.74 SLC6A2 (0.42) KMT2ASMN1; SMN2L3MBTL1PPARGPPARA
SCHEMBL5752813 0.74 SLC6A2 (0.42) KMT2ATSHRSMN1; SMN2L3MBTL1PPARA
SCHEMBL5752560 0.73 L3MBTL1 (0.44) KMT2ASMN1; SMN2L3MBTL1PPARGPPARA
SCHEMBL5751245 0.72 L3MBTL1 (0.41) KMT2AHPGDSMN1; SMN2L3MBTL1PPARG
SCHEMBL5753455 0.72 L3MBTL1 (0.41) KMT2ASMN1; SMN2L3MBTL1PPARGMAPT
SCHEMBL3572819 0.72 KMT2A (0.49) KMT2AMEN1HPGDTSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP KMT2A 404/4885MEN1 2847/4885HPGD 3316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.